1. Home
  2. IGI vs SERA Comparison

IGI vs SERA Comparison

Compare IGI & SERA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Western Asset Investment Grade Defined Opportunity Trust Inc.

IGI

Western Asset Investment Grade Defined Opportunity Trust Inc.

HOLD

Current Price

$16.06

Market Cap

96.2M

Sector

Finance

ML Signal

HOLD

Logo Sera Prognostics Inc.

SERA

Sera Prognostics Inc.

HOLD

Current Price

$2.11

Market Cap

79.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IGI
SERA
Founded
N/A
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Precision Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
96.2M
79.5M
IPO Year
2009
2021

Fundamental Metrics

Financial Performance
Metric
IGI
SERA
Price
$16.06
$2.11
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
18.8K
93.0K
Earning Date
01-01-0001
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
32.32
EPS
N/A
N/A
Revenue
N/A
$81,000.00
Revenue This Year
N/A
$875.93
Revenue Next Year
N/A
$248.39
P/E Ratio
N/A
N/A
Revenue Growth
N/A
5.19
52 Week Low
$15.70
$1.37
52 Week High
$17.09
$4.09

Technical Indicators

Market Signals
Indicator
IGI
SERA
Relative Strength Index (RSI) 55.91 46.15
Support Level $15.78 $1.72
Resistance Level $16.66 $3.59
Average True Range (ATR) 0.22 0.19
MACD 0.03 0.04
Stochastic Oscillator 54.12 65.45

Price Performance

Historical Comparison
IGI
SERA

About IGI Western Asset Investment Grade Defined Opportunity Trust Inc.

Western Asset Invstm Grd Dfnd Opp Tr Inc operates as a non-diversified closed-end management investment company. Its primary investment objective is to provide current income and then liquidate & distribute substantially all of the Fund's net assets to stockholders. As a secondary investment objective, the Fund will seek capital appreciation. The Fund seeks to achieve its investment objectives by investing at least 80% of its net assets in investment-grade corporate fixed-income securities of varying maturities.

About SERA Sera Prognostics Inc.

Sera Prognostics Inc is a health diagnostic company. It develops diagnostic tests for the early prediction of a woman's individualized risk of premature birth, preeclampsia, gestational diabetes, stillbirth, and other conditions. The proprietary proteomics and bioinformatics platform of the company helps to improve maternal and neonatal health by discovering, developing, and commercializing blood-based biomarker tests, and predictive analytic products and services. The Company operates as one operating segment, which is developing and commercializing its medical diagnostic products and services.

Share on Social Networks: